ASCEND
BY NTHRYS

NTHRYSPhD AssistanceObesidomics

Obesidomics

Field
Category

Obesidomics

Select a category to explore research frontiers

Obesidomics200 categories·80 research gap frontiers·access £41
UIRG Unique Individual Research GapFrontier Research Gap Frontier, groups 3+ UIRGsChip badge 4 UIRGs in that frontier🔓 One fee unlocks every UIRG under a frontier🧬 Illustrated: graphical abstract published
PathFieldCategoryFrontierUIRGPhD assistance services
Adipose Tissue Transcriptomics and Gene Expression
10 frontiers
10+
UIRGS
This research examines genome-wide mRNA expression patterns in white, brown, and beige adipose tissues to identify obesity-related gene regulation mechanisms.
RESEARCH GAP FRONTIERS
Transcriptional Rewiring in Browning of White Adipose TissueDepot-Specific Gene Expression Signatures Across Body TopologyLipotoxicity-Driven Transcriptome Collapse in Metabolic Disease+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Gut Microbiome Metagenomics in Obesity
10 frontiers
10+
UIRGS
Comprehensive analysis of microbial community composition and functional capacity in obese versus lean individuals using next-generation sequencing technologies.
RESEARCH GAP FRONTIERS
Microbial Metabolite Signatures in Obesity ProgressionDysbiotic Firmicutes-Bacteroidetes Ratios and Metabolic EndotoxemiaArchaeal Methanogens and Energy Harvest Efficiency+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Proteomics of Adipokine Signaling Pathways
10 frontiers
10+
UIRGS
Large-scale characterization of protein abundance and post-translational modifications in leptin, adiponectin, and inflammatory cytokine signaling networks.
RESEARCH GAP FRONTIERS
Adipokine Interactome Dynamics in Metabolic InflammationPost-Translational Modifications Orchestrating Adipokine Receptor SignalingSecretory Proteome Remodeling During Adipocyte Dysfunction+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Metabolomics of Energy Homeostasis
10 frontiers
10+
UIRGS
Investigation of metabolic fingerprints and biomarkers associated with energy balance dysregulation using mass spectrometry-based platforms.
RESEARCH GAP FRONTIERS
Lipotoxic Metabolite Signatures in Insulin ResistanceCircadian Metabolic Dysrhythmia in Obesity DevelopmentBranched-Chain Amino Acid Signaling at Energy Thresholds+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Epigenetic Modifications in Obesity Development
10 frontiers
10+
UIRGS
Study of DNA methylation, histone acetylation, and chromatin remodeling patterns that regulate obesity-susceptibility genes across tissues.
RESEARCH GAP FRONTIERS
Histone Acetylation Dynamics in Adipogenic Lineage CommitmentDNA Methylation Signatures at Metabolic Switching PointsChromatin Remodeling in White-to-Brown Adipocyte Transdifferentiation+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Single-Cell RNA Sequencing of Adipocytes
10 frontiers
10+
UIRGS
High-resolution characterization of individual adipocyte heterogeneity, differentiation states, and gene expression profiles within obese tissue.
RESEARCH GAP FRONTIERS
Transcriptional Heterogeneity Within White Adipocyte LineagesBrown Adipocyte Transdifferentiation at Single-Cell ResolutionLipid Droplet Biogenesis Gene Networks in Individual Adipocytes+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Circulating microRNA Biomarkers for Obesity
10 frontiers
10+
UIRGS
Identification and validation of cell-free microRNAs in blood plasma as non-invasive diagnostic and prognostic indicators of obesity progression.
RESEARCH GAP FRONTIERS
miRNA Signatures in Metabolic Inflexibility and Insulin ResistanceCirculating miRNA Dynamics Across the Obesity SpectrummiRNA-Mediated Adipose Tissue Inflammation and Systemic Immunity+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Immune Cell Infiltration Lipidomics
10 frontiers
10+
UIRGS
Comprehensive lipid profiling of macrophages, T cells, and other immune populations within obese adipose tissue microenvironments.
RESEARCH GAP FRONTIERS
Lipid-Mediated Polarization of Infiltrating Immune PopulationsFatty Acid Sensing in Adipose Tissue Macrophage RecruitmentOxylipins as Chemotactic Drivers of Leukocyte Infiltration+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Nutrient Sensing Pathway Genomics
Genetic and functional analysis of mTOR, AMPK, and other nutrient-sensing mechanisms that regulate metabolic adaptation in obesity.
Explore frontiers →
Extracellular Vesicle Protein Content Analysis
Characterization of exosomal and microvesicular cargo from adipose tissue as mediators of systemic metabolic dysfunction.
Explore frontiers →
Insulin Signaling Cascade Phosphoproteomics
Quantitative mapping of phosphorylation events across insulin receptor signaling networks in insulin-resistant adipocytes and muscle.
Explore frontiers →
Mitochondrial DNA Variation and Obesity
Investigation of mtDNA mutations, copy number variations, and heteroplasmy effects on mitochondrial dysfunction in obese tissues.
Explore frontiers →
Bacterial Lipopolysaccharide Endotoxemia
Analysis of gram-negative bacterial LPS translocation, TLR4 activation, and systemic inflammation mechanisms in metabolic endotoxemia.
Explore frontiers →
Brown Adipose Tissue Activators Screening
High-throughput screening of pharmacological and natural compounds that promote brown adipogenesis and thermogenic capacity.
Explore frontiers →
Hepatic Steatosis Genomic Architecture
Genome-wide association studies and functional validation of genetic variants contributing to non-alcoholic fatty liver disease.
Explore frontiers →
Gut Barrier Function and Tight Junctions
Molecular characterization of claudin, occludin, and zonula occludens proteins in intestinal permeability changes during obesity.
Explore frontiers →
Systemic Chronic Inflammation Cytokine Networks
Multiplex immunoassay profiling of TNF-alpha, IL-6, IL-1beta, and other pro-inflammatory cytokines in obese circulation.
Explore frontiers →
Intestinal Glucose Absorption and Transporters
Functional studies of SGLT1 and GLUT2 expression and activity in nutrient absorption dysregulation during obesity.
Explore frontiers →
Hypothalamic POMC Neuron Transcriptomics
Single-cell and tissue-level RNA sequencing of pro-opiomelanocortin neurons and appetite regulation circuitry in obese brains.
Explore frontiers →
Visceral Adiposity Imaging Biomarkers
Development of MRI-based biomarkers and radiomics algorithms for quantifying visceral fat distribution and metabolic risk.
Explore frontiers →
Bone Marrow Derived Macrophage Plasticity
Study of M1 to M2 macrophage polarization dynamics and metabolic reprogramming in obese adipose tissue inflammation.
Explore frontiers →
Lipid Droplet Associated Proteins
Comprehensive proteomic profiling of PLIN, CGI-58, and ATGL family proteins regulating lipid mobilization in obesity.
Explore frontiers →
Fibroblast Growth Factor Signaling Axis
Investigation of FGF21, FGF19, and FGFR signaling pathways as therapeutic targets for metabolic dysfunction.
Explore frontiers →
Oxidative Stress and Antioxidant Defense
Quantification of reactive oxygen species, lipid peroxides, and antioxidant enzyme capacity across obese tissue compartments.
Explore frontiers →
Intestinal Short Chain Fatty Acid Production
Metabolomic analysis of butyrate, propionate, and acetate production by dysbiotic microbiota and their metabolic effects.
Explore frontiers →
Adipose Tissue Fibrosis and Extracellular Matrix
Characterization of collagen deposition, TIMPs, MMPs, and fibrogenic pathways in expansion-associated adipose tissue remodeling.
Explore frontiers →
Circulating Free Fatty Acid Profiles
Lipidomic quantitation of saturated, unsaturated, and oxidized free fatty acids as lipotoxicity mediators in obesity.
Explore frontiers →
Skeletal Muscle Insulin Resistance Mechanisms
Integrated analysis of IRS-1 signaling, GLUT4 translocation, and mitochondrial dysfunction in obesity-related myopathy.
Explore frontiers →
White Adipose Browning Transcriptional Regulators
Investigation of PGC-1alpha, PRDM16, IRF4, and other transcription factors controlling beige adipocyte differentiation.
Explore frontiers →
Cardiovascular Risk Proteomic Signatures
Discovery of plasma protein panels predictive of obesity-related hypertension, atherosclerosis, and cardiac dysfunction.
Explore frontiers →
Immune Tolerance and Regulatory T Cells
Flow cytometry and transcriptomic analysis of Treg frequency, function, and differentiation in obese immune landscapes.
Explore frontiers →
Glucagon-Like Peptide Receptor Signaling
Molecular characterization of GLP-1R and GLP-2R expression, agonist binding kinetics, and downstream pathway activation.
Explore frontiers →
Pancreatic Beta Cell Dysfunction Genomics
Single-cell RNA-seq and functional studies of glucose-stimulated insulin secretion defects in obesity-related diabetes.
Explore frontiers →
Prenatal Programming of Obesity Risk
Epigenetic and metabolomic investigations of fetal programming mechanisms linking maternal obesity to offspring metabolic disease.
Explore frontiers →
Pharmacogenomic Variation in Weight Loss
Genomic analysis of genetic polymorphisms predicting response to anti-obesity medications like GLP-1 agonists and SGLT2 inhibitors.
Explore frontiers →
Tissue Cross-Talk via Exosomal miRNAs
Study of adipose-derived exosomal microRNAs regulating skeletal muscle glucose uptake and hepatic lipid metabolism.
Explore frontiers →
Lysosomal Lipid Storage Disorders
Investigation of lysosomal dysfunction, cathepsin B, and autophagy impairment contributing to lipid accumulation in obesity.
Explore frontiers →
Estrogen Receptor Signaling in Adiposity
Characterization of ERalpha and ERbeta expression and function in sex-specific differences in fat distribution and metabolism.
Explore frontiers →
Bile Acid Metabolism and FXR Signaling
Analysis of farnesoid X receptor and G protein-coupled bile acid receptor signaling in metabolic regulation during obesity.
Explore frontiers →
Neural Leptin Resistance Mechanisms
Molecular studies of leptin receptor signaling, SOCS3 expression, and central tolerance development in hypothalamic neurons.
Explore frontiers →
Ketone Body Metabolism and Energy Switching
Metabolomic and enzymatic analysis of beta-hydroxybutyrate and acetoacetate production during caloric restriction and ketogenic states.
Explore frontiers →
Vascular Endothelial Dysfunction Markers
Investigation of endothelial nitric oxide synthase, von Willebrand factor, and endothelial dysfunction in obese vasculature.
Explore frontiers →
Microbial Short Chain Fatty Acid Fermentation
Functional metagenomics of microbial carbohydrate fermentation capabilities and their influence on intestinal barrier integrity.
Explore frontiers →
Renal Function and Albuminuria Omics
Proteomic and genomic analysis of glomerular filtration rate decline and podocyte dysfunction in obesity-related nephropathy.
Explore frontiers →
Thermogenic Uncoupling Protein Expression
Quantitative analysis of UCP1, UCP2, and UCP3 expression and activity in brown adipocytes and mitochondrial thermogenesis.
Explore frontiers →
Sleep Disruption and Metabolic Consequences
Investigation of circadian rhythm disruption, melatonin signaling, and sleep-related metabolic dysregulation in obesity.
Explore frontiers →
Psychosocial Stress Hormonal Mediators
Profiling of cortisol, ACTH, and hypothalamic-pituitary-adrenal axis dysfunction linking chronic stress to obesity pathogenesis.
Explore frontiers →
Emerging Microbiota-Associated Metabolites
Discovery of novel bacterial metabolites and secondary metabolites affecting intestinal immune homeostasis and energy harvest.
Explore frontiers →
Stem Cell Differentiation and Adipogenesis
Study of bone marrow mesenchymal stem cell lineage commitment and transcriptional control during white and brown adipogenic differentiation.
Explore frontiers →
Bacterial Lipoproteins and TLR Activation
Analysis of gram-positive bacterial lipoprotein structural variants and toll-like receptor signaling in metabolic inflammation.
Explore frontiers →
Pancreatic Acinar Cell Lipotoxicity and Inflammation
Investigation of how excess lipid accumulation in pancreatic acinar cells triggers inflammatory cascades and impairs digestive enzyme secretion in obese states.
Explore frontiers →
Ectopic Lipid Deposition in Cardiac Myocytes
Analysis of mechanisms by which intramyocardial triglyceride accumulation compromises cardiac contractility and electrical stability in obesity-related cardiomyopathy.
Explore frontiers →
Adipose Tissue Macrophage Polarization Dynamics
Characterization of pro-inflammatory M1 to anti-inflammatory M2 macrophage transition states and their metabolic consequences in expanding adipose depots.
Explore frontiers →
Long Non-Coding RNA Regulation of Lipogenesis
Identification and functional validation of lncRNAs that control transcriptional and post-transcriptional pathways governing de novo fatty acid synthesis.
Explore frontiers →
Hepatic Fibrosis Staging via Molecular Signatures
Development of omics-based biomarker panels for non-invasive assessment of liver fibrosis progression in non-alcoholic fatty liver disease.
Explore frontiers →
Senescent Adipocyte Secretory Phenotype
Characterization of senescence-associated secretory factors released by dysfunctional adipocytes and their contribution to systemic metabolic dysfunction.
Explore frontiers →
Intestinal Permeability and Claudin Expression
Investigation of claudin family protein dysregulation and tight junction compromise in obesity-associated intestinal barrier dysfunction.
Explore frontiers →
Chemokine Receptor Signaling in Immune Recruitment
Mapping of CCL and CXCL ligand-receptor axes that orchestrate monocyte and dendritic cell infiltration into inflamed adipose tissue.
Explore frontiers →
Branched-Chain Amino Acid Catabolism and Insulin Resistance
Elucidation of how impaired BCAA metabolism generates lipotoxic intermediates that promote insulin signaling desensitization.
Explore frontiers →
Thrombotic Microparticle Generation and Activation
Quantification of endothelial and platelet-derived microparticles as drivers of hypercoagulability and cardiovascular risk in obesity.
Explore frontiers →
Sodium-Glucose Cotransporter Function and Glycosuria
Analysis of SGLT1 and SGLT2 expression and activity alterations in obese individuals and their impact on renal glucose reabsorption.
Explore frontiers →
Aryl Hydrocarbon Receptor Ligand Metabolism
Investigation of how microbial and dietary AhR ligand availability influences intestinal barrier integrity and immune homeostasis.
Explore frontiers →
Adipose Tissue Neovascularization and Angiogenic Factors
Study of VEGF, angiopoietin, and other pro-angiogenic signals mediating capillary network expansion during adipose tissue hyperplasia.
Explore frontiers →
Gut-Associated Lymphoid Tissue Immunophenotyping
Flow cytometric and transcriptomic profiling of Peyer''s patches and isolated lymphoid follicles in obesity-related immune dysregulation.
Explore frontiers →
Malonyl-CoA Carnitine Palmitoyltransferase Axis
Mechanistic analysis of how Malonyl-CoA/CPT-1 signaling dysregulation impairs mitochondrial fatty acid oxidation capacity.
Explore frontiers →
Adiponectin Multimerization and Receptor Specificity
Characterization of high-molecular-weight versus low-molecular-weight adiponectin isoforms and their differential AdipoR1/AdipoR2 signaling outcomes.
Explore frontiers →
Saturated Lipid Induced Endoplasmic Reticulum Stress
Elucidation of unfolded protein response activation mechanisms triggered by palmitate accumulation and adaptive versus maladaptive stress resolution.
Explore frontiers →
Tumor Necrosis Factor Receptor Superfamily Signaling
Mapping of TNF-alpha, TRAIL, and lymphotoxin-mediated inflammatory cascades and their metabolic consequences in adipose tissue.
Explore frontiers →
Circulating Lipopolysaccharide-Binding Protein Dynamics
Quantitative analysis of LBP as a biomarker for gram-negative bacterial translocation and systemic endotoxemia burden.
Explore frontiers →
Melanocortin Pathway Genetics and Rare Variants
Identification of rare loss-of-function mutations in MC4R and POMC genes contributing to monogenic and polygenic obesity risk.
Explore frontiers →
Protein Tyrosine Phosphatase 1B Regulation
Investigation of PTP1B expression and activity modulation as a therapeutic target for restoring insulin and leptin signaling.
Explore frontiers →
Hepatic De Novo Lipogenesis Gene Networks
Systems-level analysis of ChREBP and SREBP-1c transcriptional networks controlling hepatic triglyceride synthesis in obesity.
Explore frontiers →
Apolipoprotein B-100 Post-Translational Modifications
Characterization of phosphorylation, acetylation, and oxidative modifications of ApoB100 affecting VLDL particle assembly and clearance.
Explore frontiers →
Bacterial Lipoteichoic Acid and Gram-Positive Signaling
Analysis of how gram-positive bacterial cell wall components activate TLR2 and contribute to low-grade chronic inflammation.
Explore frontiers →
Sirtuin Deacetylase Activity in Metabolic Adaptation
Functional characterization of SIRT1-7 mediated deacetylation events regulating NAD-dependent metabolic switching and longevity pathways.
Explore frontiers →
Adipose Tissue Hypoxia Inducible Factor Signaling
Investigation of HIF-1-alpha and HIF-2-alpha stabilization in hypoxic microenvironments and their role in fibrosis and inflammation.
Explore frontiers →
Intestinal Farnesoid X Receptor and Secondary Bile Acids
Analysis of FXR-mediated signaling by deoxycholic acid and lithocholic acid in regulating glucose homeostasis and GLP-1 secretion.
Explore frontiers →
Systemic Inflammation Acute Phase Response Proteins
Quantification of CRP, serum amyloid A, fibrinogen, and other hepatic acute phase reactants as obesity-related inflammatory markers.
Explore frontiers →
Histone Deacetylase Inhibition and Metabolic Remodeling
Investigation of HDAC inhibition effects on adipogenic and metabolic gene expression programs in obesity intervention studies.
Explore frontiers →
Platelet Activation and P-Selectin Expression
Analysis of platelet hyperresponsiveness and increased P-selectin surface expression in obesity-related thrombotic complications.
Explore frontiers →
Apolipoprotein E Isoform Distribution and Lipid Transport
Investigation of how ApoE2, ApoE3, and ApoE4 isoforms differentially affect lipid metabolism and cognitive decline in obesity.
Explore frontiers →
Adipose Tissue Innervation and Sympathetic Signaling
Characterization of sympathetic neuron density, norepinephrine release, and beta-3 adrenergic receptor signaling in thermogenic capacity.
Explore frontiers →
Vitamin D Metabolite Levels and Immune Function
Analysis of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D concentrations and their immunomodulatory effects in obese populations.
Explore frontiers →
Fecal Calprotectin as Intestinal Inflammation Marker
Quantification of neutrophil-derived calprotectin in feces as a biomarker for intestinal barrier breakdown and mucosal immune activation.
Explore frontiers →
Amino Acid Transporter Expression and Amino Acid Availability
Investigation of LAT1, CAT1, and other amino acid transporter regulation affecting cellular amino acid uptake and signaling.
Explore frontiers →
Neutrophil Extracellular Trap Formation and Thrombosis
Analysis of NET-driven thrombotic events and their contribution to cardiovascular complications in severe obesity.
Explore frontiers →
Glycosylated Hemoglobin Prediction and Glucose Variability
Development of predictive models integrating continuous glucose monitoring data with omics signatures for improved HbA1c estimation.
Explore frontiers →
Bone Marrow Adipogenesis and Hematopoietic Suppression
Investigation of how increased marrow fat accumulation impairs hematopoietic stem cell function and immune cell production.
Explore frontiers →
Soluble Transferrin Receptor and Iron Metabolism
Analysis of iron homeostasis dysregulation in obesity and its impact on mitochondrial function and metabolic capacity.
Explore frontiers →
Fatty Acid Binding Protein Isoform Expression Patterns
Characterization of FABP1, FABP2, FABP4, and FABP6 isoform-specific roles in lipid trafficking and metabolic signaling.
Explore frontiers →
Retinoid X Receptor Heterodimer Signaling Pathways
Investigation of RXR-alpha heterodimerization with PPARs, FXR, and LXR in coordinating lipid and glucose metabolism.
Explore frontiers →
Acetyl-CoA Carboxylase Isoform Distribution
Characterization of ACC1 and ACC2 tissue-specific expression and their divergent roles in lipogenesis versus fatty acid oxidation.
Explore frontiers →
Intestinal Alkaline Phosphatase and Barrier Function
Investigation of intestinal alkaline phosphatase activity in dephosphorylating lipopolysaccharides and maintaining barrier integrity.
Explore frontiers →
Oxidized Phospholipid Accumulation and Immune Activation
Analysis of how oxidized phospholipid oxidative stress products activate innate immune receptors and perpetuate inflammation.
Explore frontiers →
Lipoprotein Lipase Activity and Triglyceride Hydrolysis
Investigation of LPL expression and post-translational regulation in adipose and muscle tissues determining lipid partitioning.
Explore frontiers →
Circulating Endothelial Cell Count and Vascular Damage
Quantification of endothelial cells shed into circulation as biomarkers for endothelial dysfunction and microvascular injury severity.
Explore frontiers →
Pentose Phosphate Pathway Enzyme Expression
Characterization of G6PD and other pentose phosphate enzyme regulation providing reducing equivalents for lipid synthesis.
Explore frontiers →
Mucin-2 Production and Mucus Layer Integrity
Investigation of MUC2 expression and mucus layer thickness as protective factors against bacterial translocation in obesity.
Explore frontiers →
Monoamine Oxidase Activity and Catecholamine Degradation
Analysis of MAO-A and MAO-B expression affecting sympathetic neurotransmitter levels and thermogenic capacity in adipose tissue.
Explore frontiers →
Tissue Glycation and Advanced Glycation Endproduct Formation
Investigation of non-enzymatic protein glycation products accumulating under chronic hyperglycemia and their RAGE-mediated inflammatory effects.
Explore frontiers →
Retinoid X Receptor Obesity Gene Regulation
Investigation of nuclear receptor signaling in lipid metabolism and adipogenesis through retinoid X receptor pathway modulation.
Explore frontiers →
Adiponectin Receptor Isoform Expression Patterns
Characterization of tissue-specific adiponectin receptor splicing variants and their metabolic consequences in obesity.
Explore frontiers →
Peroxisome Proliferator Activated Receptor Coactivators
Analysis of PGC-1 family proteins in mitochondrial biogenesis and energy expenditure regulation during obesity.
Explore frontiers →
Sterol Regulatory Element Binding Proteins Transcriptomics
Genome-wide mapping of SREBP-mediated lipogenic gene regulation in obesity-associated fatty liver disease.
Explore frontiers →
AMP Activated Protein Kinase Substrate Phosphorylation
High-resolution phosphoproteomics of AMPK signaling cascades and their dysregulation in obese tissues.
Explore frontiers →
Mammalian Target of Rapamycin Pathway Integration
Integrated analysis of mTOR signaling cross-talk with metabolic sensors in obesity-related metabolic dysfunction.
Explore frontiers →
Histone Deacetylase Activity in Metabolic Memory
Investigation of HDAC-mediated chromatin remodeling in persistent metabolic changes following obesity treatment.
Explore frontiers →
DNA Methyltransferase Target Gene Identification
Whole-genome bisulfite sequencing to map DNMT-dependent CpG methylation patterns in obese populations.
Explore frontiers →
Chromatin Immunoprecipitation Sequencing of Transcription Factors
ChIP-seq analysis of obesity-associated transcription factor binding sites and regulatory element landscape.
Explore frontiers →
Long Noncoding RNA Regulatory Networks
Systems biology approach to map lncRNA-mediated control of adipogenesis and metabolic homeostasis.
Explore frontiers →
Circular RNA Biogenesis and Obesity Pathology
Characterization of circRNA production and function as competing endogenous RNAs in obesity development.
Explore frontiers →
Transfer RNA Derived Fragments in Metabolic Regulation
Analysis of tRF-mediated stress responses and metabolic control in obesity-associated cellular dysfunction.
Explore frontiers →
Small Nucleolar RNA Processing and rRNA Modification
Investigation of snoRNA-guided pseudouridylation changes and translational efficiency in obesity.
Explore frontiers →
CRISPR Perturbation Screening in Adipocytes
Functional genomics using pooled CRISPR screens to identify obesity-relevant gene targets and regulatory dependencies.
Explore frontiers →
Spatial Transcriptomics of Adipose Tissue Architecture
High-resolution in situ transcriptomics revealing cell-cell interactions and zone-specific gene expression in obese depots.
Explore frontiers →
Multiomics Integration of Metabolic Phenotypes
Machine learning-based integration of genomic, transcriptomic, and metabolomic data for obesity subtype classification.
Explore frontiers →
Protein Phosphorylation Dynamics During Weight Loss
Temporal phosphoproteomics tracking molecular mechanism transitions accompanying therapeutic weight loss interventions.
Explore frontiers →
Ubiquitin Proteasome System Substrate Identification
Proteomics of ubiquitylated proteins and E3 ligase specificity in obesity-related protein quality control.
Explore frontiers →
Autophagy Flux Assessment in Metabolic Tissues
Advanced microscopy and molecular approaches to quantify autophagy pathway function in obese adipose and liver.
Explore frontiers →
Endoplasmic Reticulum Stress Response Signaling
Comprehensive analysis of unfolded protein response activation and integrated stress response kinases in obesity.
Explore frontiers →
Glutathione Redox Status and Thiol Proteomics
Quantitative analysis of protein S-glutathionylation and redox-sensitive cysteine modifications in obese tissues.
Explore frontiers →
Lipid Peroxidation and Carbonyl Stress Biomarkers
Detection and quantification of oxidized lipid metabolites and protein carbonylation in obesity-associated complications.
Explore frontiers →
Advanced Glycation End Product Formation Kinetics
Temporal tracking of AGE accumulation and receptor for AGE signaling in metabolic disease progression.
Explore frontiers →
Branched Chain Amino Acid Catabolism Genomics
Genetic variation and expression analysis of BCAA-degrading enzymes and metabolite accumulation in obesity.
Explore frontiers →
Aromatic Amino Acid Tryptophan Metabolite Profiling
Targeted metabolomics of tryptophan-derived metabolites including kynurenine and aryl hydrocarbon receptor ligands.
Explore frontiers →
Glycerol-3-Phosphate Shuttle Enzyme Expression
Investigation of mitochondrial glycerol-3-phosphate dehydrogenase isoforms in hepatic and adipose lipogenesis.
Explore frontiers →
Carnitine Shuttle Proteins and Fatty Acid Oxidation
Proteomic characterization of CPT1 and CPT2 regulation in impaired mitochondrial fat oxidation.
Explore frontiers →
Phosphatidylcholine Remodeling and Signaling
Lipidomics of phospholipid remodeling pathways and their role in membrane protein function in obesity.
Explore frontiers →
Ceramide Species Accumulation and Toxicity
High-resolution lipidomics of ceramide homologs and their contribution to insulin resistance and lipotoxicity.
Explore frontiers →
Sphingosine-1-Phosphate Signaling in Vascular Function
Investigation of S1P metabolism and receptor signaling in endothelial dysfunction and cardiovascular comorbidity.
Explore frontiers →
Cholesterol Ester Storage Disease Associated Genes
Genetic analysis of LIPA and neutral lipid hydrolase variants in obesity-related liver pathology.
Explore frontiers →
Lipoprotein Lipase Activity Regulation Mechanisms
Tissue-specific LPL expression and post-translational modification patterns affecting triglyceride hydrolysis efficiency.
Explore frontiers →
Apolipoprotein Expression and Particle Remodeling
Quantitative proteomics of apolipoprotein isoforms and their impact on lipoprotein particle heterogeneity.
Explore frontiers →
Hepatic Very Low Density Lipoprotein Secretion
Mechanistic study of VLDL assembly and secretion dysregulation in fatty liver disease.
Explore frontiers →
Scavenger Receptor Subtype Expression Patterns
Tissue distribution and ligand specificity of SR-A and SR-B isoforms in metabolic disease.
Explore frontiers →
LDL Particle Size Heterogeneity and Atherogenicity
Advanced lipid profiling correlating small dense LDL prevalence with oxidation susceptibility in obesity.
Explore frontiers →
HDL Composition and Reverse Cholesterol Transport
Proteomics and lipidomics of HDL particle remodeling and impaired antiatherogenic function in obesity.
Explore frontiers →
Triglyceride Rich Lipoprotein Remnant Metabolism
Kinetic analysis of postprandial TRL remnant clearance and LPL-mediated remodeling in obesity.
Explore frontiers →
Lipoprotein Associated Phospholipase A2 Activity
Investigation of Lp-PLA2 expression and oxidized phospholipid hydrolysis in atherosclerotic progression.
Explore frontiers →
Platelet Activating Factor Metabolism and Signaling
Characterization of PAF production and degradation pathways in obesity-associated vascular inflammation.
Explore frontiers →
Eicosanoid and Prostaglandin Biosynthesis Profiling
Targeted lipidomics of arachidonic acid-derived metabolites and COX/LOX enzyme expression patterns.
Explore frontiers →
Specialized Proresolving Mediators in Tissue Remodeling
Quantification of lipoxin, resolvins, and protectin production and receptor signaling in obesity resolution.
Explore frontiers →
Metabolic Endotoxemia and Microbial Translocation
Mechanistic investigation of bacterial antigen translocation pathways and pattern recognition receptor activation.
Explore frontiers →
Zonula Occludens Protein Phosphorylation States
Phosphoproteomics of tight junction claudin and ZO protein modifications in intestinal barrier integrity.
Explore frontiers →
Mucus Layer Composition and Bacterial Adherence
Proteomic analysis of mucin glycosylation and antimicrobial peptide expression affecting microbiota composition.
Explore frontiers →
Intestinal Epithelial Cell Junctional Dynamics
Real-time imaging and molecular characterization of tight junction turnover and resealing mechanisms in obesity.
Explore frontiers →
Enteroendocrine Cell Secretory Profile and GLP-1
Single-cell transcriptomics and proteomics of intestinal L-cell GLP-1 secretion regulation in obesity.
Explore frontiers →
Nutrient Sensing G Protein Coupled Receptors
Functional characterization of FFAR and TAS1R signaling in nutrient detection and metabolic control.
Explore frontiers →
Taste Receptor Expression in Metabolic Tissues
Unexpected taste receptor expression in liver and adipose tissue and metabolic signaling functions.
Explore frontiers →
Olfactory Receptor Signaling in Systemic Metabolism
Investigation of extraolfactory OR expression in adipocytes and their role in lipid metabolism control.
Explore frontiers →
Adipose Tissue Spatial Transcriptomics Architecture
Investigation of three-dimensional gene expression patterns within adipose tissue depots using spatial omics technologies to understand cellular heterogeneity and tissue organization in obesity.
Explore frontiers →
Metaproteomics of Gut Microbial Communities
Comprehensive analysis of functional protein expression from complex gut microbiota populations to identify obesity-associated microbial metabolic activities and host-microbe interactions.
Explore frontiers →
Glycolipid Composition and Immune Recognition
Characterization of glycosylated lipid structures in adipose tissue and their role in triggering innate immune responses during obesity development.
Explore frontiers →
Metabolic Heterogeneity in Adipocyte Subpopulations
Multi-omics profiling of functionally distinct adipocyte subsets to elucidate differential metabolic capabilities and their contribution to obesity pathophysiology.
Explore frontiers →
Systemic Lipid-Associated Protein Biomarkers
Discovery and validation of serum proteins complexed with lipids as diagnostic and prognostic indicators of obesity-related metabolic dysfunction.
Explore frontiers →
Chromatin Accessibility in Metabolic Tissues
ATAC-seq and related chromatin profiling to map regulatory landscape changes in adipose and hepatic tissues underlying obesity-associated gene dysregulation.
Explore frontiers →
Amino Acid Metabolism and Obesity Progression
Targeted metabolomic analysis of branched-chain and aromatic amino acid metabolism as biomarkers and mechanistic drivers of insulin resistance in obesity.
Explore frontiers →
Subcellular Lipid Organelle Proteomics
High-resolution proteomic characterization of lipid droplets, mitochondria, and peroxisomes to understand compartmentalized lipid handling in obese tissue.
Explore frontiers →
Intestinal Epithelial Barrier Permeability Markers
Integration of genomics, transcriptomics, and proteomics to identify molecular determinants of intestinal barrier dysfunction and metabolic endotoxemia in obesity.
Explore frontiers →
Systemic Extracellular Matrix Remodeling Signatures
Comprehensive analysis of circulating matrix metalloproteinases and their substrates as indicators of tissue remodeling dysregulation across obese individuals.
Explore frontiers →
Tissue-Resident Macrophage Transcriptional States
Single-cell and bulk transcriptomics of adipose tissue macrophages to define activation states and pro-inflammatory signaling in obesity-associated inflammation.
Explore frontiers →
Circulating Extracellular RNA Species Profiling
Identification and quantification of cell-free long and small RNAs in circulation as diagnostic biomarkers reflecting adipose tissue and hepatic dysfunction in obesity.
Explore frontiers →
Metabolic Endotoxemia and TLR4 Signaling Cascade
Mechanistic investigation of bacterial translocation products and their engagement with pattern recognition receptors driving systemic inflammation in obese individuals.
Explore frontiers →
Thermogenic Capacity and Brown Adipocyte Efficiency
Multi-omics assessment of brown adipocyte energy dissipation machinery including uncoupling proteins and metabolic enzyme expression in obesity context.
Explore frontiers →
Hepatic Lipid Accumulation and Gene Regulation
Integrated transcriptomic and lipidomic analysis of fatty liver disease development mechanisms and transcription factor control in obese individuals.
Explore frontiers →
Enteric Neuronal and Endocrine Cell Omics
Single-cell transcriptomics of intestinal neuroendocrine cells and enteric neurons to understand altered nutrient sensing and appetite signaling in obesity.
Explore frontiers →
Metabolite-Driven Epigenetic Remodeling Pathways
Investigation of how altered metabolite pools including acetyl-CoA and S-adenosylmethionine influence histone and DNA modifications in obese tissues.
Explore frontiers →
Fibrosis-Associated Molecular Phenotypes in Adipose
Characterization of pro-fibrotic gene signatures and collagen deposition patterns in dysfunctional adipose tissue using histology-integrated omics.
Explore frontiers →
Plasma Lipoprotein Particle Size Distribution
Advanced lipidomic and proteomic profiling of lipoprotein particles to assess atherogenic dyslipidemia patterns in obesity-related cardiometabolic disease.
Explore frontiers →
Skeletal Muscle Mitochondrial Dysfunction Indicators
Transcriptomic and proteomic analysis of mitochondrial oxidative phosphorylation and biogenesis pathways in insulin-resistant muscle of obese individuals.
Explore frontiers →
Beige Adipocyte Lineage Commitment and Markers
Single-cell transcriptomics and surface proteomics to identify molecular determinants of beige adipocyte differentiation and activation in obesity.
Explore frontiers →
Coronary Microvascular Endothelial Dysfunction
Proteomic and transcriptomic characterization of endothelial dysfunction markers and angiogenic factor dysregulation in obesity-associated heart disease.
Explore frontiers →
Microbial Carbohydrate Utilization and Fermentation
Functional genomic and metabolomic analysis of bacterial polysaccharide degradation capabilities and their metabolic outputs in obese microbiota.
Explore frontiers →
Glomerular Filtration and Podocyte Integrity
Proteomic analysis of urinary biomarkers and transcriptomic assessment of podocyte dysfunction underlying obesity-related glomerular disease progression.
Explore frontiers →
Circadian Rhythm Disruption and Metabolic Consequences
Time-series transcriptomic and metabolomic profiling to reveal clock gene dysregulation and temporal metabolic dysfunction in obese individuals.
Explore frontiers →
Somatic Mutation Burden in Adipose Tissue
Whole genome and targeted sequencing to identify age-related and obesity-driven somatic mutations and clonal expansion in adipocyte populations.
Explore frontiers →
Lipid Signaling Cascade Compartmentalization
Spatial and temporal analysis of bioactive lipid mediators and their receptor signaling localization in adipose and immune compartments.
Explore frontiers →
Dermal Fibroblast Metabolic Reprogramming
Transcriptomic and metabolomic characterization of skin fibroblast dysfunction and collagen synthesis impairment in obesity-associated complications.
Explore frontiers →
Bacterial Quorum Sensing and Host Crosstalk
Functional genomic analysis of microbial quorum sensing molecules and their detection by intestinal epithelial cells in obesity microbiota.
Explore frontiers →
Serum Albumin Glycation and Post-Translational Modifications
Proteomic characterization of glycation and oxidative modifications to serum albumin as markers of hyperglycemia and inflammation in obesity.
Explore frontiers →
Lymphoid Tissue Follicular Helper T Cell Dynamics
Single-cell transcriptomics of germinal center responses and B cell-T cell interactions in gut-associated lymphoid tissue dysfunction in obesity.
Explore frontiers →
Adipokine Receptor Signaling and Desensitization
Mechanistic investigation of leptin and adiponectin receptor downregulation and altered intracellular signal transduction in obese tissue.
Explore frontiers →
Pancreatic Islet Cell Dysfunction Trajectories
Longitudinal single-cell and spatial transcriptomics of pancreatic islet cells to characterize progressive beta cell exhaustion and glucotoxicity in obesity.
Explore frontiers →
Early Life Immune Programming and Metabolic Memory
Investigation of maternal obesity-induced epigenetic and immune system alterations that predispose offspring to metabolic dysfunction.
Explore frontiers →
Pharmacogenomic Predictors of Drug Response Variation
Genome-wide association studies combined with pharmacoproteomics to identify genetic and proteomic predictors of weight loss medication efficacy.
Explore frontiers →
Intercellular Adhesion Molecule Shedding Markers
Quantitative analysis of circulating soluble adhesion molecules and endothelial cell-derived vesicles as indicators of vascular inflammation in obesity.
Explore frontiers →
Microbiota-Derived Tryptophan Metabolite Signaling
Functional analysis of aryl hydrocarbon receptor ligands produced by commensals and their immunomodulatory effects in obesity-associated dysbiosis.
Explore frontiers →
Lysosomal Autophagy Flux and Lipophagy Pathways
Investigation of impaired autophagy and selective lipid autophagy mechanisms in adipocytes and hepatocytes contributing to lipid overload.
Explore frontiers →
Estrogen Signaling Dimorphism and Sexual Differences
Sex-stratified omics analysis of estrogen receptor alpha and beta signaling in adipose tissue explaining sexual dimorphism in obesity susceptibility.
Explore frontiers →
Secondary Bile Acid Metabolism and TGR5 Activation
Metagenomic and metabolomic assessment of bacterial bile salt hydrolase activity and secondary bile acid-mediated metabolic benefits in obesity.
Explore frontiers →
Hypothalamic Glial Cell Activation and Inflammation
Single-cell transcriptomics of microglia and astrocytes in the hypothalamus to characterize neuroinflammation underlying leptin resistance mechanisms.
Explore frontiers →
Ketone Body Metabolism in Peripheral Tissues
Integrated transcriptomic and metabolomic analysis of ketone body production and utilization capacity in liver and muscle during dietary interventions.
Explore frontiers →
Coronary Artery Atherosclerotic Plaque Omics
Tissue-based proteomics and lipidomics of atherosclerotic lesions to identify obesity-specific plaque composition and destabilization mechanisms.
Explore frontiers →
Oral Microbiota Dysbiosis and Systemic Inflammation
Metagenomic and metabolomic profiling of oral microbiota alterations in obesity and their translocation to systemic circulation.
Explore frontiers →
Bone Marrow Adiposity and Hematopoietic Niche
Transcriptomic and proteomic analysis of bone marrow adipocytes and their effects on hematopoietic stem cell function in obesity.
Explore frontiers →
Neurotrophin Signaling and Sympathetic Nerve Plasticity
Investigation of nerve growth factor and BDNF signaling in sympathetic innervation of white and brown adipose tissue in obesity.
Explore frontiers →
Protein Misfolding and Endoplasmic Reticulum Stress
Characterization of unfolded protein response activation and ER chaperone expression as mechanisms of insulin resistance in obese tissues.
Explore frontiers →
Microbial-Derived Lipopolysaccharide Structure Variants
Mass spectrometry-based structural characterization of bacterial lipopolysaccharide variants and their differential immunogenic potential in obesity dysbiosis.
Explore frontiers →
Adipose Tissue Vascular Dysfunction and Angiogenesis
Integrated analysis of endothelial cell dysfunction, impaired vasculogenesis, and hypoxia signaling in expanding adipose tissue depots.
Explore frontiers →
Fecal Calprotectin and Intestinal Inflammation Markers
Proteomic profiling of fecal biomarkers including neutrophil-derived proteins as indicators of subclinical intestinal inflammation in obesity.
Explore frontiers →